The Fourth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum Features Nation's Leading Pharmaceutical Sector Regulators and Compliance Professionals
- Sponsored by Pharmaceutical Compliance Forum
- November 12 - 14, 2003
- Renaissance Marriott Hotel, Washington, DC
Contact: Paul Tunnecliff
WASHINGTON DC USA -- HEALTHCARE UPDATE NEWS SERVICETM - SEPTEMBER 10, 2003: The Pharmaceutical Compliance Forum, the leading association of pharmaceutical industry compliance professionals, announced today the scheduling of its Fourth Annual Pharmaceutical Regulatory Compliance Congress and Best Practices Forum, which will be held November 12 - 14, 2003, in Washington, DC. See www.PharmaCongress.com.
SPONSOR: THE PHARMACEUTICAL COMPLIANCE FORUM:
The Congress is sponsored by the Pharmaceutical Compliance Forum (PCF). PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry, to promote effective corporate compliance programs. The organization is open to others in the industry, and has more than doubled its membership since it was founded. The members meet twice a year, for 1-2 days, focusing on open and informal sharing of compliance information, best practices and current developments in the field.
Thomas L. Abrams
Director, Division of Drug Marketing, Advertising & Communications, U.S. Food and Drug Administration, Rockville, MD
Arthur L. Caplan, Ph.D.
Director, Center for Bioethics, University of Pennsylvania, Fellow, American Association for the Advancement of Science, the Hastings Center, the College of Physicians of Philadelphia, and the New York Academy of Medicine, Philadelphia, PA
Acting Principal Deputy Inspector General, Office of Inspector General, Department of health and Human Services, Washington, DC
Chairman, President and CEO, Merck & Co., Inc., Whitehouse Station, NJ
John Guthrie, Esq.
Director, Medicaid Fraud Control Unit, Office of Attorney General, Columbus, OH
Thomas B. Leary, Esq.
Commissioner, Federal Trade Commission, Washington, DC
Michael Loucks, Esq.
Chief of the Health Care Fraud Unit, Assistant U.S. Attorney, U.S. Attorney's Office for the District of Massachusetts, Boston, MA
Mark B. McClellan, MD, Ph.D.
Commissioner of Food and Drugs, Food and Drug Administration, Rockville, MD
Dennis M. Nally
Chairman and Senior Partner, PricewaterhouseCoopers LLP, New York, NY
Administrator, Center for Medicare and Medicaid Services, Department of Health and Human Services,Washington, DC
James Sheehan, Esq.
Chief of the Civil Division, Assistant U.S. Attorney, U.S. Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA
Janet Woodcock, MD
Director, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD
Douglas M. Lankler, Esq.
Senior Corporate Counsel, Deputy Compliance Officer, Pfizer Inc., New York, NY
Arjun Rajaratnam, Esq.
Compliance Officer, Global Pharmaceuticals, GlaxoSmithKline, Research Triangle Park, NC
Bert Weinstein, Esq.
Vice President and Assistant General Counsel, Merck & Co., Whitehouse Station, NJ
Chief Privacy Officer, Novartis, East Hanover, NJ
Alexis Leslie Barbieri, Esq.
Deputy Attorney General, Office of Attorney General, Harrisburg, PA
Compliance Director, AstraZeneca, Wilmington, DE
John Bentivoglio, Esq.
Partner, Arnold and Porter, Former Special Counsel for Healthcare Fraud, Chief Privacy Officer, United States Department of Justice,
Raymond A. Bonner, Esq.
Partner, Sidley Austin Brown & Wood, Washington, DC
Mary Devlin Capizzi, Esq.
Partner, Gardner Carton & Douglas, Washington, DC
Heidi Chen, Esq.
Senior Corporate Counsel, Pfizer Inc., New York, NY
Senior Adviser, E-Business, North American Commercial Operations, Aventis Pharmaceuticals, Bridgewater, NJ
Eve Costopoulos, Esq.
Staff Vice President, Compliance, Schering-Plough Corporation, Law Department, Kenilworth, NJ
Stanley W. Crosley, Esq.
Chief Privacy Officer, Eli Lilly and Company, Law Division, Indianapolis, IN
Teri Crouse, Esq.
Director of Compliance for Healthcare and Marketing, Eli Lilly and Company, Indianapolis, IN
Brian A. Dahl, Esq.
Counsel, Takeda Pharmaceuticals North America, Inc., Lincolnshire, IL
Sujata T. Dayal Esq.
Counsel, Domestic Legal Operations, Abbott Laboratories, Abbott Park, IL
Anthony L. Farino
Partner, PricewaterhouseCoopers, Chicago, IL
William T. Fitzgerald, Esq.
Director, Global Compliance, Alcon Laboratories, Inc., Fort Worth, TX
Allison J. Gassaro Esq.
Senior Attorney, NA Legal, Aventis Pharmaceuticals, Bridgewater, NJ
Gary Giampetruzzi, Esq.
Compliance Counsel, Pfizer Inc., New York, NY
Senator Chuck Grassley (R/IA) (Invited)
United States Senate, Chairman, Senate Finance Committee, Washington, DC
Robert G. Homchick, Esq.
Partner and Chair, Health Law Group, Davis Wright Tremaine, Seattle, WA
Peter Barton Hutt, Esq,
Partner, Covington & Burling, Former Chief Counsel, Food and Drug Administration, Washington, DC
Oliver Johnson, II
Chief Privacy Officer, Merck & Co., Whitehouse Station, NJ
Paul E. Kalb, MD, JD
Partner, Sidley Austin Brown & Wood, Washington, DC
Peter Keisler, Esq. (Invited)
Assistant Attorney General, Civil Division, United States Department of Justice, Washington, DC
Mark Allen Kleiman, Esq.
Partner, Law Offices of Mark Allen Kleiman, Los Angeles, CA
Kathleen A. Knight, Esq.
Vice President, Deputy General Counsel and Assistant Secretary, Alcon Laboratories, Inc., Fort Worth, TX
Richard P. Kusserow
President, Strategic Management Systems, Inc., Former Inspector General, Department of Health & Human Services, Washington, DC
Arthur N. Levine, Esq.
Partner, Arnold & Porter, Former Deputy Chief Counsel for Litigation, Food and Drug Administration, Washington, DC
Robert S. Litt, Esq.
Partner, Arnold & Porter, Former Principal Associate Deputy Attorney General, United States Department of Justice, Washington, DC
Justin McCarthy Esq.
Assistant General Counsel, Global Research and Development, Pfizer Inc., New London, CT
Stephen Meagher, Esq.
Partner, Phillips & Cohen, San Francisco, CA
Ed Miller, Esq.
Boehringer Ingelheim Pharmaceuticals
David Moskowitz, MBA, R.PH
Senior Vice President and Healthcare Senior Analyst, Friedman, Billings, Ramsey Group, Inc., Washington, DC
Edwin D. Rauzi, Esq.
Partner, Davis Wright Tremaine, Seattle, WA
Janet Rehnquist, Esq.
Partner, Venable LLP, Former Inspector General, Department of Health & Human Services, Washington, DC
Partner, PricewaterhouseCoopers, Florham Park, NJ
Michele Russell-Einhorn, Esq.
Director, Clinical Research Consulting Team, PricewaterhouseCoopers, Former Director of Regulatory Affairs, Office for Human Research Protection, Washington, DC
Brenton L. Saunders, JD, MBA
Partner, PricewaterhouseCoopers, Past President, Health Care Compliance Association, Founder and Chair-elect, International Association of Privacy Officers, Florham Park, NJ
Catherine A. Sazdanoff
Divisional Vice President, Ethics and Compliance, Abbott Laboratories, Abbott Park, IL
Director, International Compliance, Schering-Plough Corporation, Kenilworth, NJ
Jonathan A. Smollen
Chief Privacy Officer, Wyeth Pharmaceuticals, St. Davids, PA
Executive Director, Litigation, Novartis Pharmaceuticals Corporation, East Hanover, NJ
Vice President, Public Policy, Merck & Co., Inc., Washington, DC
Bert Spilker, PhD, MD, FCP, FFPM
President, Bert Spilker & Associates, Clinical Professor, Pharmacy Practice, University of Minnesota, Former Senior Vice President of Scientific and Regulatory Affairs, PhRMA, Bethesda, MD
Jane Stratton, Esq.
Vice President Associate General Counsel, And Chief Compliance Officer, Chiron Corporation, Emeryville, CA
Michael P. Swiatocha
Director, PricewaterhouseCoopers, Florham Park, NJ
Paul A. Sundberg Esq.
Staff Counsel, Commercial Legal Operations, Takeda Pharmaceuticals North America, Inc., Lincolnshire, IL
The Honorable Tommy Thompson (Invited)
Secretary, Department of Health and Human Services, Washington, DC
L. Stephan Vincze, Esq.
Ethics & Compliance Officer, TAP Pharmaceuticals, Lake Forest, IL
Caroline H. West, Esq.
Vice President, Global Legal Compliance, Legal Compliance Group, Aventis Pharmaceuticals, Bridgewater, NJ
EXHIBIT & SPONSORSHIP INFORMATION:
For sponsorship and exhibit information review the Promotional Opportunities pages on the Congress website: http://www.PharmaCongress.com or contact:
For further registration info, call 800-684-4549, email: firstname.lastname@example.org, or write:
Pharma Congress Office
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS:
7790 Barberry Ave.
Yucca Valley, CA USA 92284
Please email your request to: webmaster@PharmaCongress.com.